Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hamid Ghodse

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 13, 2012
2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol): A preliminary reviewJohn M Corkery, Simon Elliott, Fabrizio Schifano, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 12, 2012
The recreational tryptamine 5-MeO-DALT (N,N-diallyl-5-methoxytryptamine): a brief reviewJohn M Corkery, Emma Durkin, Simon Elliott, et al.
BMC Public Health|June 8, 2006
Fatal injuries while under the influence of psychoactive drugs: a cross-sectional exploratory study in EnglandAdenekan Oyefeso, Fabrizio Schifano, Hamid Ghodse, et al.
BMC Medical Education|February 19, 2014
Substance misuse teaching in undergraduate medical educationJanine Carroll, Christine Goodair, Andrew Chaytor, et al.
British Journal of Clinical Pharmacology|January 18, 2011
Deaths of opiate/opioid misusers involving dihydrocodeine, UK, 1997-2007Giuliano Zamparutti, Fabrizio Schifano, John M Corkery, et al.
The American Journal on Addictions|April 13, 2012
Impact of an 18-month, NHS-based, treatment exposure for heroin dependence: results from the London Area Treat 2000 StudyFabrizio Schifano, Giovanni Martinotti, Anna Cunniff, et al.
Human Psychopharmacology|July 25, 2013
MDAI (5,6-methylenedioxy-2-aminoindane; 6,7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine; 'sparkle'; 'mindy') toxicity: a brief overview and updateJohn M Corkery, Simon Elliott, Fabrizio Schifano, et al.
BMJ (Clinical Research Ed.)|January 11, 2003
Review of deaths related to taking ecstasy, England and Wales, 1997-2000Fabrizio Schifano, Adenekan Oyefeso, Lucy Webb, et al.
Drug and Alcohol Dependence|October 18, 2003
Cause and manner of death in drug-related fatality: an analysis of drug-related deaths recorded by coroners in England and Wales in 2000Lucy Webb, Adenekan Oyefeso, Fabrizio Schifano, et al.
Human Psychopharmacology|June 16, 2005
Buprenorphine mortality, seizures and prescription data in the UK, 1980-2002Fabrizio Schifano, John Corkery, Eilish Gilvarry, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 13, 2012
2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol): A preliminary reviewJohn M Corkery, Simon Elliott, Fabrizio Schifano, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 12, 2012
The recreational tryptamine 5-MeO-DALT (N,N-diallyl-5-methoxytryptamine): a brief reviewJohn M Corkery, Emma Durkin, Simon Elliott, et al.
BMC Public Health|June 8, 2006
Fatal injuries while under the influence of psychoactive drugs: a cross-sectional exploratory study in EnglandAdenekan Oyefeso, Fabrizio Schifano, Hamid Ghodse, et al.
BMC Medical Education|February 19, 2014
Substance misuse teaching in undergraduate medical educationJanine Carroll, Christine Goodair, Andrew Chaytor, et al.
British Journal of Clinical Pharmacology|January 18, 2011
Deaths of opiate/opioid misusers involving dihydrocodeine, UK, 1997-2007Giuliano Zamparutti, Fabrizio Schifano, John M Corkery, et al.
The American Journal on Addictions|April 13, 2012
Impact of an 18-month, NHS-based, treatment exposure for heroin dependence: results from the London Area Treat 2000 StudyFabrizio Schifano, Giovanni Martinotti, Anna Cunniff, et al.
Human Psychopharmacology|July 25, 2013
MDAI (5,6-methylenedioxy-2-aminoindane; 6,7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine; 'sparkle'; 'mindy') toxicity: a brief overview and updateJohn M Corkery, Simon Elliott, Fabrizio Schifano, et al.
BMJ (Clinical Research Ed.)|January 11, 2003
Review of deaths related to taking ecstasy, England and Wales, 1997-2000Fabrizio Schifano, Adenekan Oyefeso, Lucy Webb, et al.
Drug and Alcohol Dependence|October 18, 2003
Cause and manner of death in drug-related fatality: an analysis of drug-related deaths recorded by coroners in England and Wales in 2000Lucy Webb, Adenekan Oyefeso, Fabrizio Schifano, et al.
Human Psychopharmacology|June 16, 2005
Buprenorphine mortality, seizures and prescription data in the UK, 1980-2002Fabrizio Schifano, John Corkery, Eilish Gilvarry, et al.
Pageof 6